MedTrace Logo

Validation of the Cervicothoracic Differentiation Test

NCT06287242 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-07-11

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effects of two spinal manipulations in adults between the ages of 18-65 based on the results of a non-invasive clinical test. The main question it aims to answer is: • Does matched or unmatched region of manipulation based on the CTDT result in greater reduction of pain levels and improvement in range of motion in adults with neck pain compared to unmatched manipulations? Participants will be asked to:

* rate their pain with neck movement, complete brief questionnaires about their pain,
* have their neck range of motion measured,
* perform a test known as the cervico-thoracic differentiation test (CTDT),
* receive either a cervical or thoracic manipulation,
* repeat the range of motion measurements.
* A second session will occur 7-10 days later where questionnaires and range of motion measures will be repeated.

Researchers will compare the effects of manipulation matched to CTDT test result to individuals in the unmatched CTDT manipulation group to see if the CTDT may indicate which region will provide a greater treatment effect for individuals with neck pain.

Conditions

  • Neck Pain

Interventions

OTHER

spinal manipulation

High velocity, low amplitude (HVLA) manipulation of the cervical or thoracic spine

Sponsors & Collaborators

  • University of Hartford

    lead OTHER

Principal Investigators

  • Brian Swanson, PT, DSc · University of Hartford

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-20
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06287242 on ClinicalTrials.gov